US Patent 11242375 Immune cell compositions and methods of use
Patent 11242375 was granted and assigned to Memorial Sloan Kettering Cancer Center on February, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 2, 2016
Date of Patent
February 8, 2022
Patent Applicant
Patent Application Number
15757276
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11242375 Immune cell compositions and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.